InGen BioSciences Announced Comprehensive Offering of in Vitro Diagnostics in France With the Signature of Exclusive Distribution Partnerships With Quidel Corporation (QDEL)and Diagnostic Hybrids, Inc.
8/20/2012 8:07:14 AM
More...
|
Diagnostic Hybrids, Inc. Receives Approval from Chinese SFDA for D3(R) Ultra(TM) DFA Respiratory Virus Screening and ID Kit
7/1/2010 10:17:23 AM
More...
|
Diagnostic Hybrids, Inc. Receives FDA Emergency Use Authorization for D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
2/24/2010 7:04:43 AM
More...
|
Diagnostic Hybrids, Inc. Receives FDA Emergency Use Authorization for D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
2/23/2010 1:06:51 PM
More...
|
Quidel Corporation (QDEL) Completes Acquisition of Diagnostic Hybrids, Inc.
2/22/2010 10:15:13 AM
More...
|
Diagnostic Hybrids, Inc. Announces FDA Clearance of D3(R) FastPointTM L-DFA(TM) RSV/MPV Identification Kit
1/12/2010 9:59:34 AM
More...
|
Quidel Corporation (QDEL) to Buy Diagnostic Hybrids, Inc. for $130 Million
1/11/2010 6:50:00 AM
More...
|
Diagnostic Hybrids, Inc. Sponsors Graves' Disease Foundation's Patient and Family Education Conference
11/18/2009 8:40:02 AM
More...
|
Diagnostic Hybrids, Inc. Announces FDA Clearance of D3(R) FastPointTM L-DFATM Influenza A/ Influenza B Virus Identification Kit
10/27/2009 2:33:33 PM
More...
|
Diagnostic Hybrids, Inc. Announces FDA Clearance of D3(R) FastPointTM L-DFATM Respiratory Virus Identification Kit
9/15/2009 6:56:00 AM
More...
|
|